Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin krka filmuhúðuð tafla 30 mg
krka sverige ab - mirtazapinum inn - filmuhúðuð tafla - 30 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin krka filmuhúðuð tafla 45 mg
krka sverige ab - mirtazapinum inn - filmuhúðuð tafla - 45 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin bluefish munndreifitafla 15 mg
bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 15 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
míron filmuhúðuð tafla 15 mg
teva b.v.* - mirtazapinum inn - filmuhúðuð tafla - 15 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
míron filmuhúðuð tafla 30 mg
teva b.v.* - mirtazapinum inn - filmuhúðuð tafla - 30 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
míron smelt munndreifitafla 15 mg
teva b.v.* - mirtazapinum inn - munndreifitafla - 15 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
míron smelt munndreifitafla 30 mg
teva b.v.* - mirtazapinum inn - munndreifitafla - 30 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin bluefish munndreifitafla 30 mg
bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 30 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin krka filmuhúðuð tafla 15 mg
krka sverige ab - mirtazapinum inn - filmuhúðuð tafla - 15 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.